JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.14B
| $272K | ﹤0.01% |
5,390
-1,077
| -17% | -$53.8K |
|
4352
iShares US Transportation ETF
IYT
$2.3B
| $272K | ﹤0.01% |
5,872
-195,996
| -97% | -$9.25M |
|
4353
Denali Therapeutics
DNLI
$4.04B
| $271K | ﹤0.01% |
13,170
+2,101
| +19% | +$47.1K |
|
4354
iShares MSCI Chile ETF
ECH
$1.03B
| $271K | ﹤0.01% |
6,669
-178,881
| -96% | -$7.41M |
|
4355
Upland Software
UPLD
$14.9M
| $271K | ﹤0.01% |
617
+233
| +61% | +$107K |
|
4356
Univest Financial
UVSP
$1.18B
| $271K | ﹤0.01% |
10,558
-314
| -3% | -$7.88K |
|
4357
Zillow
ZG
$7.53B
| $271K | ﹤0.01% |
6,119
+441
| +8% | +$17.3K |
|
4358
National Healthcare
NHC
$3.47B
| $270K | ﹤0.01% |
3,357
-995
| -23% | -$76.8K |
|
|
FOMX
4359
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $270K | ﹤0.01% |
112,536
+22,027
| +24% | +$65.8K |
|
4360
Codexis
CDXS
$175M
| $269K | ﹤0.01% |
14,521
+1,971
| +16% | +$38K |
|
|
MFGP
4361
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $269K | ﹤0.01% |
10,470
-202,145
| -95% | -$5.34M |
|
4362
iShares Core International Aggregate Bond Fund
IAGG
$11.4B
| $267K | ﹤0.01% |
4,912
+4,617
| +1,565% | +$247K |
|
4363
CALL
Invitation Homes
INVH
$17.7B
| $265K | ﹤0.01% |
+10,000
| New | +$255K |
|
|
FIT
4364
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $265K | ﹤0.01% |
61,166
-345,055
| -85% | -$1.74M |
|
4365
Apyx Medical
APYX
$126M
| $264K | ﹤0.01% |
44,050
-129,371
| -75% | -$703K |
|
|
TRVN
4366
DELISTED
Trevena, Inc.
TRVN
| $264K | ﹤0.01% |
+414
| New | +$341K |
|
4367
Anika Therapeutics
ANIK
$295M
| $261K | ﹤0.01% |
6,601
-17,324
| -72% | -$632K |
|
|
NEOS
4368
DELISTED
Neos Therapeutics, Inc
NEOS
| $261K | ﹤0.01% |
215,900
+204,481
| +1,791% | +$376K |
|
|
STFC
4369
DELISTED
State Auto Financial Corp
STFC
| $261K | ﹤0.01% |
7,564
+922
| +14% | +$31.3K |
|
4370
Dime Commercial Bancshares
DCOM
$1.81B
| $260K | ﹤0.01% |
9,054
-2,907
| -24% | -$86.3K |
|
4371
Griffon
GFF
$4.75B
| $260K | ﹤0.01% |
15,701
+3,083
| +24% | +$52.7K |
|
4372
iShares Core MSCI Pacific ETF
IPAC
$2.78B
| $260K | ﹤0.01% |
4,687
-2,823
| -38% | -$156K |
|
4373
iShares US Home Construction ETF
ITB
$2.37B
| $260K | ﹤0.01% |
6,866
-338,124
| -98% | -$12.8M |
|
4374
Coeur Mining
CDE
$19.3B
| $259K | ﹤0.01% |
61,299
+11,657
| +23% | +$41K |
|
4375
VanEck Agribusiness ETF
MOO
$972M
| $258K | ﹤0.01% |
3,882
-27,089
| -87% | -$1.72M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.